Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 7908072, 18 pages
https://doi.org/10.1155/2017/7908072
Research Article

Alleviation of Oxidative Damage and Involvement of Nrf2-ARE Pathway in Mesodopaminergic System and Hippocampus of Status Epilepticus Rats Pretreated by Intranasal Pentoxifylline

1Department of Neurobiology, Hebei Medical University, Shijiazhuang, Hebei 050017, China
2Department of Human Anatomy, Shijiazhuang Medical College, Shijiazhuang, Hebei 050599, China
3Department of Human Anatomy, Hebei Medical University, Shijiazhuang, Hebei 050017, China
4Department of Neurology, Children’s Hospital of Hebei Province, Shijiazhuang, Hebei 050017, China

Correspondence should be addressed to Geming Shi; moc.361@gnimegihs

Received 3 December 2016; Revised 6 February 2017; Accepted 21 February 2017; Published 12 March 2017

Academic Editor: Luciano Saso

Copyright © 2017 Yunxiao Kang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Al-Mufti and J. Claassen, “Neurocritical care: status epilepticus review,” Critical Care Clinics, vol. 30, no. 4, pp. 751–764, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ahmad, “Protective effects of curcumin against lithium-pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats,” Saudi Journal of Biological Sciences, vol. 20, no. 2, pp. 155–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Kälviäinen, “Intranasal therapies for acute seizures,” Epilepsy and Behavior, vol. 49, pp. 303–306, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Zelcer and R. D. Goldman, “Intranasal midazolam for seizure cessation in the community setting,” Canadian Family Physician, vol. 62, no. 7, pp. 559–561, 2016. View at Google Scholar · View at Scopus
  5. J. J. Lochhead and R. G. Thorne, “Intranasal delivery of biologics to the central nervous system,” Advanced Drug Delivery Reviews, vol. 64, no. 7, pp. 614–628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Serralheiro, G. Alves, A. Fortuna, and A. Falcão, “Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting,” European Journal of Pharmaceutical Sciences, vol. 60, pp. 32–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Serralheiro, G. Alves, A. Fortuna, and A. Falcão, “Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice,” International Journal of Pharmaceutics, vol. 490, no. 1-2, pp. 39–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Anderson, P. Tambe, H. Sammons, H. Mulla, R. Cole, and I. Choonara, “Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers,” European Journal of Clinical Pharmacology, vol. 68, no. 2, pp. 155–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Holsti, B. L. Sill, S. D. Firth, F. M. Filloux, S. M. Joyce, and R. A. Furnival, “Prehospital intranasal midazolam for the treatment of pediatric seizures,” Pediatric Emergency Care, vol. 23, no. 3, pp. 148–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Folbergrová, P. Ješina, N. Kubová, R. Druga, and J. Otáhal, “Status epilepticus in immature rats is associated with oxidative stress and mitochondrial dysfunction,” Frontiers in Cellular Neuroscience, vol. 10, article 136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Mishra, B. Shuai, M. Kodali et al., “Resveratrol treatment after status epilepticus restrains neurodegeneration and abnormal neurogenesis with suppression of oxidative stress and inflammation,” Scientific Reports, vol. 5, Article ID 17807, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. N. Pearson, S. Rowley, L.-P. Liang, A. M. White, B. J. Day, and M. Patel, “Reactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy,” Neurobiology of Disease, vol. 82, pp. 289–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Carmona-Aparicio, C. Pérez-Cruz, C. Zavala-Tecuapetla et al., “Overview of Nrf2 as therapeutic target in epilepsy,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 18348–18367, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Davies, M. E. Delsignore, and S. W. Lin, “Protein damage and degradation by oxygen radicals. II. Modification of amino acids,” Journal of Biological Chemistry, vol. 262, no. 20, pp. 9902–9907, 1987. View at Google Scholar · View at Scopus
  15. L. Packer and E. Cadenas, “Oxidants and antioxidants revisited. New concepts of oxidative stress,” Free Radical Research, vol. 41, no. 9, pp. 951–952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Freitas, S. M. M. Vasconcelos, F. C. F. Souza, G. S. B. Viana, and M. M. F. Fonteles, “Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats,” FEBS Journal, vol. 272, no. 6, pp. 1307–1312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Lafon-Cazal, S. Pietri, M. Culcasi, and J. Bockaert, “NMDA-dependent superoxide production and neurotoxicity,” Nature, vol. 364, no. 6437, pp. 535–537, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. E. K. Michaelis, “Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging,” Progress in Neurobiology, vol. 54, no. 4, pp. 369–415, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Basar, L. Nahar, O. A. Oridupa et al., “Utilization of the ability to induce activation of the nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) to assess potential cancer chemopreventive activity of liquorice samples,” Phytochemical Analysis, vol. 27, no. 5, pp. 233–238, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Miller, I. N. Singh, J. A. Wang, and E. D. Hall, “Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice,” Experimental Neurology, vol. 264, pp. 103–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-K. Kwak, K. Itoh, M. Yamamoto, and T. W. Kensler, “Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter,” Molecular and Cellular Biology, vol. 22, no. 9, pp. 2883–2892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Ahmad, H. Zhuang, and S. Doré, “Heme oxygenase-1 protects brain from acute excitotoxicity,” Neuroscience, vol. 141, no. 4, pp. 1703–1708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Chen, Q. Fang, J. Zhang, D. Zhou, and Z. Wang, “Role of the Nrf2-ARE pathway in early brain injury after experimental subarachnoid hemorrhage,” Journal of Neuroscience Research, vol. 89, no. 4, pp. 515–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Wang, Y. Wu, G. Zhang et al., “Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure,” Brain Research, vol. 1544, pp. 54–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ahmad, G. M. Abu-Taweel, A. E. Aboshaiqah, and J. S. Ajarem, “The effects of quinacrine, proglumide, and pentoxifylline on seizure activity, cognitive deficit, and oxidative stress in rat lithium-pilocarpine model of status epilepticus,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 630509, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Tariq, M. Ahmad, K. A. Moutaery, and S. A. Deeb, “Pentoxifylline ameliorates lithium-pilocarpine induced status epilepticus in young rats,” Epilepsy and Behavior, vol. 12, no. 3, pp. 354–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Bozzi and E. Borrelli, “The role of dopamine signaling in epileptogenesis,” Frontiers in Cellular Neuroscience, vol. 7, article no. 157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. M. De Freitas, F. C. F. De Sousa, S. M. M. Vasconcelos, G. S. B. Viana, and M. M. D. F. Fonteles, “Acute alterations of neurotransmitters levels in striatum of young rat after pilocarpine-induced status epilepticus,” Arquivos de Neuro-Psiquiatria, vol. 61, no. 2B, pp. 430–433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Ciumas, T.-B. R. Wahlin, A. Jucaite, P. Lindstrom, C. Halldin, and I. Savic, “Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy,” Neurology, vol. 71, no. 11, pp. 788–794, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Odano, A. Varrone, I. Savic et al., “Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter—application to juvenile myoclonic epilepsy,” NeuroImage, vol. 59, no. 4, pp. 3582–3593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. I. Rojo, C. Montero, M. Salazar et al., “Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice,” European Journal of Neuroscience, vol. 24, no. 7, pp. 1874–1884, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. J. Racine, “Modification of seizure activity by electrical stimulation: II. Motor seizure,” Electroencephalography and Clinical Neurophysiology, vol. 32, no. 3, pp. 281–294, 1972. View at Publisher · View at Google Scholar · View at Scopus
  33. R. R. González, R. F. Fernández, J. L. M. Vidal, A. G. Frenich, and M. L. G. Pérez, “Development and validation of an ultra-high performance liquid chromatography-tandem mass-spectrometry (UHPLC-MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples,” Journal of Neuroscience Methods, vol. 198, no. 2, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Curia, D. Longo, G. Biagini, R. S. G. Jones, and M. Avoli, “The pilocarpine model of temporal lobe epilepsy,” Journal of Neuroscience Methods, vol. 172, no. 2, pp. 143–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Dubé, S. Boyet, C. Marescaux, and A. Nehlig, “Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat,” Experimental Neurology, vol. 167, no. 2, pp. 227–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. D. B. Clifford, J. W. Olney, A. Maniotis, R. C. Collins, and C. F. Zorumski, “The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures,” Neuroscience, vol. 23, no. 3, pp. 953–968, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Zhao, T. Nagao, G. C. Desjardins, P. Gloor, and M. Avoli, “Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with long-term pilocarpine seizures,” Epilepsy Research, vol. 17, no. 3, pp. 237–247, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Druga, H. Kubová, L. Suchomelová, and R. Haugvicová, “Lithium/pilocarpine status epilepticus-induced neuropathology of piriform cortex and adjoining structures in rats is age-dependent,” Physiological Research, vol. 52, no. 2, pp. 251–264, 2003. View at Google Scholar · View at Scopus
  39. H. Kubová, P. Mareš, L. Suchomelová, G. Brožek, R. Druga, and A. Pitkänen, “Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis,” European Journal of Neuroscience, vol. 19, no. 12, pp. 3255–3265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Martinc, I. Grabnar, and T. Vovk, “Antioxidants as a preventive treatment for epileptic process: a review of the current status,” Current Neuropharmacology, vol. 12, no. 6, pp. 527–550, 2014. View at Google Scholar · View at Scopus
  41. T. C. Diniz, J. C. Silva, S. R. G. de Lima-Saraiva et al., “The role of flavonoids on oxidative stress in epilepsy,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 171756, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Cardenas-Rodriguez, B. Huerta-Gertrudis, L. Rivera-Espinosa et al., “Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1455–1476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. H. F. Poon, V. Calabrese, G. Scapagnini, and D. A. Butterfield, “Free radicals and brain aging,” Clinics in Geriatric Medicine, vol. 20, no. 2, pp. 329–359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. N. G. Innamorato, A. Jazwa, A. I. Rojo et al., “Different susceptibility to the parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1,” PLoS ONE, vol. 5, no. 7, Article ID e11838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Kumar, S. Koppula, I.-S. Kim, S. V. More, B.-W. Kim, and D.-K. Choi, “Nuclear factor erythroid 2 - related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death,” CNS and Neurological Disorders—Drug Targets, vol. 11, no. 8, pp. 1015–1029, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-H. Tsou, C.-T. Shih, C.-H. Ching et al., “Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity,” Experimental Neurology, vol. 263, pp. 50–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Zhang, S. Li, Y. Kang et al., “Enhancement of dopaminergic activity and region-specific activation of Nrf2-ARE pathway by intranasal supplements of testosterone propionate in aged male rats,” Hormones and Behavior, vol. 80, pp. 103–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Zhang, K. J. A. Davies, and H. J. Forman, “Oxidative stress response and Nrf2 signaling in aging,” Free Radical Biology and Medicine, vol. 88, pp. 314–336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Ishii, K. Itoh, S. Takahashi et al., “Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages,” Journal of Biological Chemistry, vol. 275, no. 21, pp. 16023–16029, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. F. A. D. T. G. Wagener, H. E. Van Beurden, J. W. Von den Hoff, G. J. Adema, and C. G. Figdor, “The heme-heme oxygenase system: a molecular switch in wound healing,” Blood, vol. 102, no. 2, pp. 521–528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Iskander, J. Li, S. Han, B. Zheng, and A. K. Jaiswal, “NQO1 and NQO2 regulation of humoral immunity and autoimmunity,” Journal of Biological Chemistry, vol. 281, no. 41, pp. 30917–30924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. A. K. Jaiswal, “Regulation of genes encoding NAD(P)H: quinone oxidoreductases,” Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 254–262, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Dong, H. Shang, Y. Q. Chen, L. Pan, M. Bhatia, and J. Sun, “Sulforaphane protects pancreatic acinar cell injury by modulating Nrf2-mediated oxidative stress and NLRP3 inflammatory pathway,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7864150, 12 pages, 2016. View at Publisher · View at Google Scholar
  54. K. Takayama, H. Kaneko, K. Kataoka et al., “Nuclear factor (Erythroid-Derived)-related factor 2-associated retinal pigment epithelial cell protection under blue light-induced oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8694641, 9 pages, 2016. View at Publisher · View at Google Scholar
  55. W. Wang, W.-P. Wang, G.-L. Zhang et al., “Activation of Nrf2-ARE signal pathway in hippocampus of amygdala kindling rats,” Neuroscience Letters, vol. 543, pp. 58–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. P.-C. Chen, M. R. Vargas, A. K. Pani et al., “Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2933–2938, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Jazwa, A. I. Rojo, N. G. Innamorato, M. Hesse, J. Fernández-Ruiz, and A. Cuadrado, “Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism,” Antioxidants and Redox Signaling, vol. 14, no. 12, pp. 2347–2360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. A. I. Rojo, N. G. Innamorato, A. M. Martín-Moreno, M. L. De Ceballos, M. Yamamoto, and A. Cuadrado, “Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease,” GLIA, vol. 58, no. 5, pp. 588–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. D. Kraft, D. A. Johnson, and J. A. Johnson, “Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult,” Journal of Neuroscience, vol. 24, no. 5, pp. 1101–1112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Fornstedt, E. Pileblad, and A. Carlsson, “In vivo autoxidation of dopamine in guinea pig striatum increases with age,” Journal of Neurochemistry, vol. 55, no. 2, pp. 655–659, 1990. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Slivka and G. Cohen, “Hydroxyl radical attack on dopamine,” Journal of Biological Chemistry, vol. 260, no. 29, pp. 15466–15472, 1985. View at Google Scholar · View at Scopus
  62. S. Kwiecień, T. Brzozowski, P. C. Konturek et al., “Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines,” Journal of Physiology and Pharmacology, vol. 55, no. 2, pp. 337–355, 2004. View at Google Scholar · View at Scopus
  63. L. J. Marques, L. Zheng, N. Poulakis, J. Guzman, and U. Costabel, “Pentoxifylline inhibits TNF-α production from human alveolar macrophages,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 2, pp. 508–511, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. M. A. E. Ahmed and S. A. El-Awdan, “Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression,” Hormones and Behavior, vol. 73, pp. 186–199, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Kobayashi, M.-I. Kang, H. Okawa et al., “Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2,” Molecular and Cellular Biology, vol. 24, no. 16, pp. 7130–7139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Waldbaum, L.-P. Liang, and M. Patel, “Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpine-induced epileptogenesis,” Journal of Neurochemistry, vol. 115, no. 5, pp. 1172–1182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. A. A. Hussain, “Intranasal drug delivery,” Advanced Drug Delivery Reviews, vol. 29, no. 1-2, pp. 39–49, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Pires, A. Fortuna, G. Alves, and A. Falcão, “Intranasal drug delivery: how, why and what for?” Journal of Pharmacy and Pharmaceutical Sciences, vol. 12, no. 3, pp. 288–311, 2009. View at Publisher · View at Google Scholar · View at Scopus